Tech and AI Stocks Retreat as Markets Eye Upcoming Retail Earnings; HCW Biologics Skyrockets

The U.S. stock market experienced a day of cautious trading on Friday, May 15th, 2026, as major indexes trended slightly lower amid a pullback in the technology and semiconductor sectors. Investors appeared to be locking in profits following a period of volatility, while simultaneously shifting their focus toward a heavy slate of retail earnings and high-stakes technology reports scheduled for the coming week.

Major Index Performance

As of Friday afternoon, the broader markets are seeing modest declines. The State Street SPDR S&P 500 ETF Trust (SPY), which tracks the benchmark S&P 500 index, is down 0.17%. The tech-heavy Invesco QQQ Trust (QQQ), representing the Nasdaq Composite, is underperforming the broader market with a decline of 0.19%. Meanwhile, the blue-chip State Street SPDR Dow Jones Industrial Average ETF Trust (DIA) and the small-cap iShares Russell 2000 ETF (IWM) are both trading lower by 0.16%.

Despite the general downward pressure, certain sectors are finding support. The State Street Materials Select Sector SPDR ETF (XLB) rose 0.3%, and the State Street Utilities Select Sector SPDR ETF (XLU) gained 0.23%, suggesting a defensive rotation as investors move away from growth-oriented assets.

Tech and AI Sector Headwinds

The technology sector is facing significant pressure today, particularly within the semiconductor and artificial intelligence industries. The VanEck Semiconductor ETF (SMH) fell 0.22%, led by a sharp decline in Micron Technology, Inc. (MU), which dropped 4.5% on high trading volume. Nvidia Corp (NVDA), a bellwether for the AI trade, also saw its shares slide 2.9% as the market anticipates its quarterly results next week. Other notable decliners in the space include Sandisk Corporation (SNDK), which fell 3.2%.

This sentiment is reflected in the iShares A.I. Innovation and Tech Active ETF (BAI), which is currently down 0.31%. Investors are likely recalibrating expectations for AI-related growth ahead of the "main event" earnings release from Nvidia on Wednesday.

Corporate News and Premarket Movers

While the major indexes are sluggish, several individual stocks have made explosive moves. HCW Biologics Inc. (HCWB) is the day's standout performer, with its stock price skyrocketing by 232.3% on massive volume. Other significant gainers include Auddia Inc. (AUUD), up 73.8%, and Super League Enterprise, Inc. (SLE), which climbed 63.6%.

On the losing side, ARS Pharmaceuticals, Inc. (SPRY) saw its shares tumble 19.9%, while Robo.ai Inc. (AIIO) dropped 24.1%. In the pharmaceutical space, Apellis Pharmaceuticals, Inc. (APLS) remained flat despite seeing significant trading activity.

Earnings Recap and Upcoming Events

The Friday morning earnings session featured several international financial institutions and industrial players. Mitsubishi UFJ Financial Group, Inc. (MUFG) and Mizuho Financial Group, Inc. (MFG) both reported their latest quarterly results, providing insight into the global banking landscape. Additionally, RBC Bearings Incorporated (RBC) and H World Group Limited (HTHT) released their figures before the opening bell.

While the "after-close" schedule for this Friday is relatively quiet, the market is bracing for a pivotal week ahead. On Monday, May 18th, Baidu, Inc. (BIDU) and Ryanair Holdings plc (RYAAY) will report before the open, followed by Trip.com Group Limited (TCOM) after the close.

The retail sector will take center stage starting Tuesday, with Home Depot, Inc. (HD) reporting, followed by Target Corporation (TGT), Lowe's Companies Inc. (LOW), and TJX Companies, Inc. (TJX) on Wednesday. These reports will be critical in determining the health of the U.S. consumer and could dictate market direction for the remainder of the month. Finally, the week will culminate in the highly anticipated earnings from Nvidia Corp (NVDA) on Wednesday afternoon, which remains the most significant catalyst for the tech sector.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Scroll to Top